Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.50 |
| ▸ | CES1 | P23141 | 3/20 | 0.50 |
| ▸ | ESR1 | P03372 | 5/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.48 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7174103 | 0.88 | CES2 (0.50) | CES2CES1ESR1ESR2CYP19A1 | |
| SCHEMBL349595 | 0.88 | CES2 (0.50) | CES2CES1ESR1ESR2CYP19A1 | |
| SCHEMBL5279624 | 0.88 | CES2 (0.50) | CES2CES1ESR1ESR2CYP19A1 | |
| SCHEMBL1027804 | 0.84 | CES2 (0.47) | CES2CES1ESR1ESR2CYP19A1 | |
| SCHEMBL11011931 | 0.82 | CES1 (0.48) | CES2CES1MAPTSMN1; SMN2L3MBTL1 | |
| SCHEMBL29117890 | 0.81 | TSHR (0.47) | CES2CES1ESR1ESR2CYP19A1 | |
| SCHEMBL27654691 | 0.81 | ESR1 (0.45) | CES2CES1ESR1ESR2CYP19A1 | |
| SCHEMBL29117565 | 0.80 | ALDH1A1 (0.54) | CES2CES1ESR1ESR2CYP19A1 | |
| SCHEMBL27654693 | 0.80 | CES2 (0.43) | CES2CES1ESR1ESR2CYP19A1 | |
| SCHEMBL3314631 | 0.79 | ESR1 (0.61) | CES2CES1ESR1ESR2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199519-A1 | ARYL/ALKENYL-PENTENAL DERIVATIVES AS AROMA CHEMICALS | BASF SE (DE) | 2024-06-20 | — | — | US | disclosed |
| US-20240199516-A1 | DIALKYLPENTENE ETHER AND DIALKYLPENTADIENE ETHER DERIVATIVES AS FRAGRANCES | BASF SE (DE) | 2024-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199519-A1 | ARYL/ALKENYL-PENTENAL DERIVATIVES AS AROMA CHEMICALS | AHR, ARNT, TRPA1 | CES2 626/4885CES1 2171/4885ESR1 262/4885 |
| US-20240199516-A1 | DIALKYLPENTENE ETHER AND DIALKYLPENTADIENE ETHER DERIVATIVES AS FRAGRANCES | DEK, TRPA1, DGKI | CES2 534/4885CES1 1109/4885ESR1 178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.